BrainCool: €12.5m

 

Case

03/21/24
BrainCool AB, an innovative leader in medical device technology, has successfully secured 12.5 million euros in venture debt financing from the European Investment Bank (EIB). This substantial loan agreement not only underscores the high potential of BrainCool and its technology but also ensures long-term financial support for its products soon to be introduced to the market. GAEU Consulting played a pivotal role as a strategic project advisor in facilitating this process.  

"The loan agreement with EIB further validates BrainCool’s cutting-edge technology, underpinning our goal to become a major player in the medical device market. This agreement supports our ambitious plan to develop an extensive clinical pipeline of groundbreaking therapies, initially focusing on stroke, then expanding to sudden cardiac arrest and oncology. Throughout this process, GAEU Consulting has offered invaluable support, including strategic project advice, assistance during due diligence, and financial modelling expertise. We strongly recommend GAEU as a highly experienced EIB advisor."  

- Martin Waleij, CEO of BrainCool

Previous
Previous

PharmNovo: €17.5m

Next
Next

Compular: €5.3m